We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current IKNA market cap is 71.42M. The company's latest EPS is USD -1.4125 and P/E is -1.05.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.19M | 659k | 0 | 0 | 0 |
| Operating Income | -19.5M | -21.91M | -18.23M | -15.82M | -12.41M |
| Net Income | -17.34M | -19.49M | -16.15M | -13.73M | -10.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.75M | 9.19M | 30.99M | 15.62M | 9.16M |
| Operating Income | -18.49M | -44.52M | -34.14M | -70.9M | -75.42M |
| Net Income | -16.82M | -44.26M | -34.12M | -68.77M | -68.17M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 215.34M | 192.09M | 172.78M | 157.49M | 148.99M |
| Total Liabilities | 28.15M | 22.34M | 17.44M | 14.63M | 14.76M |
| Total Equity | 155.34M | 169.76M | 155.35M | 142.86M | 134.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 85.97M | 168.4M | 247.88M | 172.26M | 192.09M |
| Total Liabilities | 68.57M | 63.47M | 40M | 25.29M | 22.34M |
| Total Equity | -61.46M | -101.05M | 207.88M | 146.97M | 169.76M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -57.92M | -79.74M | -18.3M | -30.81M | -39.74M |
| Investing | 43.77M | 64.14M | -48.74M | -44.82M | -35.37M |
| Financing | 75.92M | 75.98M | N/A | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 47.93M | -37.83M | -60.25M | -74.11M | -79.74M |
| Investing | -316k | 2.92M | -1.76M | -99.28M | 64.14M |
| Financing | 16.32M | 116.18M | 131.74M | 1.1M | 75.98M |
| Market Cap | 71.42M |
| Price to Earnings Ratio | -1.05 |
| Price to Sales Ratio | 7.85 |
| Price to Cash Ratio | 0.6 |
| Price to Book Ratio | 0.42 |
| Dividend Yield | - |
| Shares Outstanding | 48.26M |
| Average Volume (1 week) | 89.2k |
| Average Volume (1 Month) | 147.86k |
| 52 Week Change | 11.28% |
| 52 Week High | 1.94 |
| 52 Week Low | 1.22 |
| Spread (Intraday) | 0.03 (2.01%) |
| Company Name | Ikena Oncology Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.ikenaoncology.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
